Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
ProBioGen AG
ProBioGen AG
Activities:
Manufacturing
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Manufacturing
ProBioGen appoints Alfred Merz as CEO
Dr Merz joins from Bayer Pharmaceuticals as CEO, focusing on developing the global reach of ProBioGen
Manufacturing
ProBioGen and DIOSynVax partner to manufacture multivalent vaccine for hemorrhagic fever
The novel vaccine targets HF diseases caused by Ebola, Marburg, and Lassa viruses
Regulatory
ProBioGen granted new patent for DirectedLuck transposase technology
ProBioGen announces that the Japan Patent Office (JPO) issued the first patent for the company’s DirectedLuck technology
Drug Delivery
ProBioGen and ImmunOs Therapeutics team up on therapy for cancer patients
ProBioGen previously developed the cell line and the manufacturing process and provided the initial clinical material for ImmunOs' innovative biologic
Manufacturing
ProBioGen enters technology collaboration with Boehringer Ingelheim
It contributes to Boehringer Ingelheim's goal of using cutting-edge technologies across the whole biopharmaceutical value chain
Manufacturing
ProBioGen and Thermo Fisher Scientific team up on cell platform
The new kit uses Thermo Fisher's ExpiCHO-S cell line and a new powerful media platform specifically developed for it
Manufacturing
ProBioGen and City of Hope announce commercial licence for manufacturing
The agreement will allow City of Hope to manufacture its MVA-based CMV vaccine using ProBioGen’s platform
Subscribe now